Your browser doesn't support javascript.
loading
High-Efficiency Lentiviral Transduction of Human CD34+ Cells in High-Density Culture with Poloxamer and Prostaglandin E2.
Uchida, Naoya; Nassehi, Tina; Drysdale, Claire M; Gamer, Jackson; Yapundich, Morgan; Demirci, Selami; Haro-Mora, Juan J; Leonard, Alexis; Hsieh, Matthew M; Tisdale, John F.
Affiliation
  • Uchida N; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI) and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, MD, USA.
  • Nassehi T; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI) and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, MD, USA.
  • Drysdale CM; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI) and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, MD, USA.
  • Gamer J; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI) and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, MD, USA.
  • Yapundich M; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI) and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, MD, USA.
  • Demirci S; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI) and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, MD, USA.
  • Haro-Mora JJ; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI) and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, MD, USA.
  • Leonard A; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI) and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, MD, USA.
  • Hsieh MM; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI) and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, MD, USA.
  • Tisdale JF; Cellular and Molecular Therapeutics Branch, National Heart Lung and Blood Institutes (NHLBI) and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, MD, USA.
Mol Ther Methods Clin Dev ; 13: 187-196, 2019 Jun 14.
Article in En | MEDLINE | ID: mdl-30788387
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Mol Ther Methods Clin Dev Year: 2019 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Mol Ther Methods Clin Dev Year: 2019 Type: Article Affiliation country: United States